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Abstract: Acinetobacter baumannii is a Gram-negative coccoid rod species, clinically relevant as a
human pathogen, included in the ESKAPE group. Carbapenem-resistant A. baumannii (CRAB) are
considered by the World Health Organization (WHO) as a critical priority pathogen for the research
and development of new antibiotics. Some of the most relevant features of this pathogen are its
intrinsic multidrug resistance and its ability to acquire rapid and effective new resistant determinants
against last-resort clinical antibiotics, mostly from other ESKAPE species. The presence of plasmids
and mobile genetic elements in their genomes contributes to the acquisition of new antimicrobial
resistance determinants. However, although A. baumannii has arisen as an important human pathogen,
information about these elements is still not well understood. Current genomic analysis availability
has increased our ability to understand the microevolution of bacterial pathogens, including point
mutations, genetic dissemination, genomic stability, and pan- and core-genome compositions. In this
work, we deeply studied the genomes of four clinical strains from our hospital, and the reference
strain ATCC®19606TM, which have shown a remarkable ability to survive and maintain their effective
capacity when subjected to long-term stress conditions. With that, our aim was presenting a detailed
analysis of their genomes, including antibiotic resistance determinants and plasmid composition.
Keywords: Acinetobacter baumannii; ESKAPE pathogens; antimicrobial determinants; plasmids;
bioinformatics; WGS; Illumina
1. Introduction
The discovery of penicillin in 1928 marked the beginning of the antibiotic era, which
meant a revolution in public health. However, their wrong utilization in the last decades
has significantly increased the number of antimicrobial-resistant strains [1]. Despite the
fact that multidrug-resistant bacteria pose a threat to both global morbidity and mortality,
pharmaceutics research and development has not been able to meet the clinical need for
new antibiotics. As a consequence, the World Health Organization (WHO) has created “a
priority list of antibiotic-resistant bacteria”, in which the Acinetobacter genus is included [2].
Acinetobacter spp. are Gram-negative coccoid rods, mostly of an environmental origin, but
with some species being clinically relevant as human pathogens, especially A. baumannii,
a human pathogenic one included in the ESKAPE group [3]. Importantly, carbapenem-
resistant A. baumannii (CRAB) strains are considered by the WHO as critical priority
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pathogens for the research and development of new antibiotics due to their limiting
therapeutic options [2]. A. baumannii is usually described as a low virulence pathogen, with
its lethality being associated with the activation of the immune system due to its highly
toxic lipopolysaccharide (LPS) [4,5]. As a human opportunistic pathogen, it is usually
associated with the most critical patients in Intensive Care Units (ICUs) in whom they could
cause bacteremia, pneumonia, and different wound infections, among other things [6,7].
Some of the most important features of this pathogen are being naturally antimicrobial-
resistant, and being able to acquire rapid and effective new resistant determinants against
last-resort clinical antibiotics [4], mostly from Pseudomonas, Salmonella, or Escherichia
strains [6]. Therefore, antibiotic resistance genes should be closely surveilled in Acine-
tobacter strains isolated at the clinical setting. For a long time, their natural antibiotic
resistance was considered a consequence of the low wall permeability, but now it is known
that antimicrobial efflux pumps are crucial for this phenotype [8,9]. As the definition of
multidrug-resistant (MDR) in practice depends on the genus, for Acinetobacter, the following
terms have been suggested [10]: (i) MDR, resistant to three different antimicrobial classes;
(ii) XDR (extensively drug-resistant), resistant to more than one compound in all except two
antimicrobial classes (MDR resistant to carbapenem); (iii) PDR (pandrug-resistant), resistant
to all compounds in every antimicrobial class (XDR resistant to polymyxin and tigecycline).
Notably, PDR strains from diverse sources have already been described [11–13]. A. bau-
mannii strains display the main antimicrobial-resistant mechanisms described for other
Gram-negative bacteria. Beta-lactam resistance in Acinetobacter species is associated with a
broad repertoire of β-lactamases, which confer resistance against penicillin, cephalosporins,
and carbapenems. Within this group, the most common in A. baumannii are oxacillinases
(OXAs), with more than 400 different enzymes clustered in six homology groups with
different targets [5]: OXA-51, chromosomic and intrinsic, the biggest subgroup; OXA-23,
chromosomic or plasmid; OXA-40/24, acquired carbapenemases; and OXA-58, OXA-143,
and OXA-48, more recently described as having low hydrolytic activity. The presence of
plasmids and other mobile genetic elements in A. baumannii genomes contributes to its abil-
ity to acquire new resistance mechanisms rapidly [14]. Moreover, a replicon-based typing
method for A. baumannii resistance plasmids has been recently proposed [15]. However,
although A. baumannii has arisen as an important human pathogen, information about
these genetic elements is still not well understood.
Nowadays, genomic analysis from whole-genome sequencing (WGS) has increased
our ability to evaluate bacterial pathogens’ microevolution, which includes point mu-
tations, antimicrobial-resistant determinant dissemination, genomic stability across the
world, and both pan- and core-genome compositions [16]. These new tools, as well as
genetic manipulation, have allowed us to gain a better comprehension of some of these
pathogens’ features, such as host–pathogen interaction mechanisms, their virulence fac-
tors, and their environmental survival ability [17–19]. The presence or absence of classic
virulence factors, evidenced by robust animal or cellular models, is of special interest due
to the link to its pathogenicity with the activation of the host’s immune system [20,21]. In
this species, the presence of iron uptake mechanisms is remarkable and is related to its
survival ability, acinetobactin being the most common and studied system whose presence
is strain-specific [19].
Four A. baumannii clinical strains isolated in our hospital and included in this study
showed a remarkable ability to survive and maintain their effective capacity when sub-
jected to stress conditions, such as those found by nosocomial bacteria in the hospital
conditions, despite their lack of virulence in cell models, which is the key point for their
transmission [22,23]. Considering the above, the aim of this work was to present a detailed
analysis of plasmids and antibiotic resistance determinants.
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2. Results
2.1. Genomic Annotations and Subsystem Categories
Genome sizes and % GC, subsystem and predicted protein-coding sequences (CDS)
by RAST and Prokka annotations, and the sequence typing are shown in Table 1. Genome
sizes range from 3.81 Mb to 4.06 Mb, all of them with a GC content of around 39% (±0.1).
The RAST annotation yielded between 3556 and 3882 protein-coding sequences, belonging
to between 451 and 462 subsystems, while Prokka annotation predicted between 3542 and
3886 CDS.
Table 1. Draft A. baumannii genomes features according to RAST and Prokka annotation. In ATCC19606
and HUMV2471, one repeat region was also identified in each strain. CDS, coding sequences.
Strains
ATCC19606 HUMV1319 HUMV2471 HUMV2790 HUMV3743
Contigs 96 110 108 118 176
Size (bp) 3,914,294 3,916,888 3,810,872 3,935,804 4,006,761
% GC 39.1 39 38.9 39 39
Subsystems 462 451 453 453 451
CDS
RAST 3689 3703 3556 3706 3882
Prokka 3667 3680 3542 3689 3886
tRNA 64 63 64 62 63
mRNA 1 1 1 1 1
rRNA 3 3 3 3 2
MLST
Oxford ST921 ST106 ST350 ST218
Pasteur ST52 ST3 ST49 ST2 ST2
The average of the CDS included in each subsystem is shown in Figure 1. Most
belonged to metabolism and molecular compounds such as amino acids and carbohydrates,
among other things. Between 75 and 96 CDS fit into the “Virulence and defense” subsystem
category (mean = 84.6 ± 11.47 standard deviation -SD-), where antimicrobial resistance-
related genes are included.
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2.2. Strain Comparison and Pan-Genome Analysis
A matrix created using Average Nucleotide Identity (ANI) and DNA-DNA hybri-
dation (DDH) values shows the relationship and similarities among our A. baumannii
and reference strains (ATCC®19606TM and AYE) (Figure 2). Both methods indicated that
HUMV2790 and HUMV3743 strains were the most similar (100 and 96.8% as ANI and
DDH values, respectively), while HUMV1319 and HUMV3743 were the most far among
them according to DDH value (83.1%).
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The five strains’ pan-genome was composed of 5244 genes, while the core-genome was
composed of 2911 genes, the former being the total number of different CDS and the latter
being the number of them shared among all the group. Figure 3 shows the relationship
among the isolates, with the numbers signifying the common CDS for each couple or
group. Again, the strains HUMV2790 and HUMV3743 are the couple that shares the largest
number of genes (362), with the lowest being between HUMV1319 and HUMV3743 (2).
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2.3. Susceptibility of A. baumannii to Antimicrobial Agents
The MICs for the seven compounds tested are shown in Table 2. Strains HUMV2790
and HUMV3743, isolated from skin ulcer and wound exudate, respectively, were resistant
to the all the tested compounds. The five strains were resistant to ampicillin, meropenem,
and erythromycin.
Table 2. Susceptibility of A. baumannii strains against seven antimicrobial agents. Isolates were
classified as resistant according to EUCAST breakpoints [24]. For the resistance profile: COL (C)
is colistin; MER (M) is meropenem; AMP (A) is ampicillin; GEN (G) is gentamicin; CIP (P) is
ciprofloxacin; TET (T) is tetracycline; and ERY (E) is erythromycin. MIC is minimum inhibitory
concentration; MIC50 is MIC that inhibits 50% of the isolates; MIC90 is MIC that inhibits 90% of the
isolates. * No specific value for Acinetobacter, used general no species-specific breakpoints. ** CLSI
breakpoints used [25].
COL MER AMP * GEN CIP TET ** ERY ResistanceProfile
M
IC
ATCC19606 2 4 >64 4 >0.25 1 >128 MAE
HUMV1319 2 >16 >64 >128 >4 8 >128 MAGPTE
HUMV2471 2 >16 >64 >128 >4 16 32 MAGPTE
HUMV2790 8 4 >64 8 >4 >32 >128 CMAGPTE
HUMV3743 4 >16 >64 >128 >4 >32 64 CMAGPTE
MIC50 2 >16 >64 >32 >4 16 >128
MIC90 >8 >16 >64 >32 >4 >32 >128
Range
(mg/L) 0.125–8 0.25–16 1–64 0.5–32 0.06–4 0.5–32 2–128
2.4. Antimicrobial Resistance Determinants
In Table 3, the antimicrobial resistance genes detected for each strain are shown and
related to their resistance to aminoglycosides, β-lactams, and sulfonamides.
Table 3. Antimicrobial resistance genes identified with Prokka and CARD databases.
STRAINS

































ADC-25 OXA-51 (66)OXA-51 (109)
All strains carried at least one aminoglycoside modifying enzyme (AME), the type
and number of them among the isolates being variable. The reference strain was the only
one susceptible to gentamicin, which only harbors one AME encoding gene (ant(3”)-IIa).
The strains HUMV1319 and HUMV3743 showed the biggest repertoire of AME genes, with
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representation of the three enzymatic classes: acetyltransferases (AAC), nucleotidyltrans-
ferases (ANT), and phosphotransferases (APH). Related to β-lactam compound resistance,
all the strains carried two encoding genes for the chromosomic endogenous class D β-
lactamase OXA-51, with different allotypes and an Acinetobacter-derived cephalosporinase
(ADC). The strains HUMV1319 and HUMV2471 also presented a commonly plasmid-
harbored blaOXA-24/40 gene. Additionally, three out the five strains carried the gene sul,
related to sulfonamide resistance.
All the clinical samples were resistant to ciprofloxacin (Table 2). In all of them, point
mutations in quinolone resistance-determining regions (QRDR) of gyrA and parC genes
were detected. In the gyrA gene, the amino acid substitution Ser-81→Leu-81 was common
for all the strains. However, in the parC product, the Ser-84→Leu-84 mutation was present
in all strains except HUMV2471, which showed a replacement in Glu-88→Lys-88. A.
baumannii numbering was used in both cases.
Related to colistin resistance, mutations in lpxACD and pmrAB were mapped. The
LpxA subunit showed no variations among the strains; LpxC showed a substitution Asp-
287 → Asn-287 in ATCC®19606TM, while in LpxD, different strains harbored different
mutations: in HUMV2471, Val-63 → Ile-63; in HUMV1319, Glu-73 → Asp-73; and in
HUMV2790 and HUMV3743 (both colistin-resistant), Glu-117→ Lys-117. In regard to the
pmrAB operon, in position 119 of PmrA, the HUMV1319 presented a Thr while the others
had a Ser. The 4 clinical strains harbored His-440 in PmrB instead of the Asn-400 of the
reference strain ATCC®19606TM. The plasmid-borne gene mcr-1, also related to colistin
resistance, was not detected in any strain.
All the strains harbored a broad repertoire of efflux pumps genes, including resistance-
nodulation-cell division (RND) multidrug efflux pumps (AdeABC, AdeFGH, and AdeIJK),
small multidrug resistance (SMR) (AbeS), and multidrug and toxic extrusion (MATE)
(AbeM) family efflux pumps. Regulatory genes adeL and adeN were also identified in all
the strains, related to adeFGH and adeIJK overexpression respectively, as well as the adeRS
operon (adeABC), except HUMV2471, which only presented the adeR subunit.
2.5. Plasmid Prediction and Analysis
Using Bertini et al. [15] specific resistance plasmid primers, positive results (Figure 4A)
were obtained for all the strains in three different typing groups (GR): ATCC®19606TM
GR8; HUMV1319, HUMV2471, and HUMV2790 GR2; and HUMV3743 GR6.
Through a PFGE electrophoresis after an S1 digestion plasmid, the presence of plas-
mids was obtained for HUMV2471, HUMV2790, and HUMV3743 strains, with sizes ranging
from 48.5 to 145.5 kb (ladder) (Figure 4B).
The PLACNETw server predicted putative plasmids in all A. baumannii Illumina draft
genomes analyzed (Figure S1): in ATCC®19606TM, two putative small plasmids of 11 and
15 kb; in HUMV1319, a small 8.90 kb plasmid and three smaller accessory structures from
1 to 7 kb with not enough identity to be considered as plasmids; in HUMV2471, two big
plasmids of 118.39 and 69.2 kb and two small ones of 6 and 8.95 kb; in HUMV2790, a
105.1 kb big plasmid and an 11.55 kb small one; and in HUMV3743, two big plasmids of
over 107 kb and 78.73 kb.
The 15 kb plasmid of strain ATCC®19606TM harbored a MOBQ class relaxase (detected
by PLACNETw). This is a mobilizable plasmid and no genes coding for a Type IV Secretion
System have been detected. Plasmid pMAC (NCBI: NC_006877) is the most similar plasmid
with a 99.97% ANI.
The 8.90 kb plasmid of strain HUMV1319, the 8.95 kb plasmid of HUMV2471, and
the 11.55 kb plasmid of HUMV2790 are a group of similar plasmids to plasmid pMMCU3
(NCBI: NC_019199). The ANI is 100%, 99.87% and 99.95% respectively.
PLACNETw detected a MOBF class relaxase in the 69.2 kb plasmid of strain HUMV2471
and in the 78.73 kb plasmid from HUMV3743. Moreover, both plasmids are putative con-
jugative plasmids as, in addition to the relaxase, they had genes coding for a Type IV
Secretion System (traA, traL, traE, traK, traB, traV, traC, traW, traU, traN, traN, traH, traG,
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trwB, and trwC). Plasmid pD72-2 (NCBI: NC_025111) is one of the most similar plasmids in
NCBI with an ANI of 99.9% for both plasmids.
According to PLACNETw, plasmid pABUH5-114 (NCBI: NZ_AYOI01000002) is a
similar structure to the 107 kb plasmid of strain HUMV3743 and the 105.1 kb plasmid
of HUMV2790. However, even with both being large plasmids, no known relaxase nor
replicon was found in either plasmid. The case is similar for the 118.39 kb plasmid of
strain HUMV2471, but the reference plasmid is pABTJ2 (NCBI: NC_020524) with a 99.52%
ANI. For the 6 kb plasmid of strain HUMV2471, the reference plasmid is pRAY (NCBI:
NC_025068) with a 100% ANI.
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2.6. Virulence Factors
Gene clusters related to siderophores (acinetobactin, actinoferrin) and aryl polyene
(berninamycin) detected using antiSMASH were common in all strains and others, as K53
capsular polysaccharide (HUMV2790 and HUMV3743) was only present in some isolates.
Analysis of virulence genes in the strains used in this study revealed the existence of a few
classical virulence genes in all of them. The virulence of the strains would be related only
to genes responsible for the synthesis of lipopolysaccharide and structural genes for the
formation of the capsule. These virulence genes are listed in Table S1.
3. Discussion
We performed a bioinformatic analysis of five draft genomes from four A. baumannii
clinical isolates from a Spanish hospital, and a reference strain showing a high level
of resistance to most antimicrobials tested. These strains have been previously studied
and do not show virulence in vitro [22]. The data from the genomic analysis agree with
these results, revealing only a few genes classically implicated in the virulence of other
Gram-negative pathogens (Table S1). On the other hand, some of them have a marked
resistance to environmental conditions, which makes them very persistent in hospital
settings [23]. This is consistent with the presence of capsular polysaccharides, which may
play a relevant role in such survival under adverse environmental conditions, protecting
them from external factors, including desiccation. The capsule also protects bacteria
from phagocytosis, although these strains were easily captured by human neutrophils
in vitro [20].
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We evaluated their susceptibility to seven antibiotics. All the strains showed resis-
tance to meropenem, ampicillin, and erythromycin. Strains also presented resistance to
gentamicin, ciprofloxacin, and tetracycline. Only two strains showed resistance to the
last-resort antibiotic colistin. These strains could only be considered as MDR because
only one compound for each class was tested [10]. These results are in concordance with
previous studies that highlight the high prevalence of antimicrobial resistance among A.
baumannii strains [12,26].
The increased accessibility to WGS platforms has led to a growing number of se-
quenced bacterial genomes, which allows performing comparative analysis to be more
comprehensive and complete. Genomic sequencing allows, among other things, identifi-
cation of putative virulence factors, possible targets for diagnosis, treatment, or vaccine
development, and/or identification of colonized patients in hospital outbreaks [27,28].
Comparative genomic analysis can also help in the identification of regions for the acquisi-
tion and/or spread of antimicrobial resistance, as well as the degree of variability among
genome estimation [28,29].
The Acinetobacter genus, in particular A. baumannii, has aroused a lot of interest for its
speed and apparent ease to acquire new antimicrobial resistance mechanisms. In this work,
different databases (ResFinder and CARD) were used to identify antimicrobial resistance
determinants, efflux pump encoding genes (only detected by CARD), and point mutations
in target antimicrobial related genes (MEGA7, PointFinder) [30–32]. PointFinder was
unable to determine the specific modifications related to the resistance phenotype, so they
were manually mapped.
Related to aminoglycoside resistance, eight genes encoding AMEs were identified (two
AAC, two ANT, and four APH), and were previously described for this bacterium [26,33–35].
The most prevalent gene was ant(3”)-IIa, common to all strains, including ATCC®19606TM,
which was the only strain with gentamicin susceptibility, so these genes should be related
to resistance to other aminoglycosides (Table 3).
Regarding β-lactams resistance, all strains harbored at least one cephalosporinase en-
coding gene (ampC), with a wide variety of allotypes (four enzymes in five strains) (Table 3).
The most prevalent isoform was ADC-25, encoding for the closest strains HUMV2790 and
HUMV3743 previously identified [36,37]. As for oxacillinase genes, all strains carried many
types, the endogenous blaOXA-51 being the most common with two different isoforms in
each strain (six different isoforms in total). Surprisingly, ATCC®19606TM and HUMV2471
strains harbored the same varieties, as well as HUMV2790 and HUMV3743 between them.
Strains HUMV1319 and HUMV2471 carried an additional blaOXA-24/40 gene, commonly
plasmid-located (such as pMMCU3) [38]. The gene blaOXA-23 was not identified in our
strains, although it was the most prevalent in other studies [39,40].
Other mechanisms to promote an MDR phenotype are point mutations in target an-
timicrobial proteins, such as for quinolones and colistin. Quinolone targets are DNA gyrase
subunit A (gyrA) and topoisomerase IV (parC), whose mutations are typically concentrated
in QRDR [6,33]. Among our clinical isolates, all showed a Ser81Leu (A. baumannii number-
ing) substitution, the ATCC®19606TM strain being the only one susceptible to ciprofloxacin,
which harbored the serine residue at position 81. For parC, HUMV2471 had a Glu88Lys
substitution, while the other three strains presented a Ser84Leu replacement. While gyrA
and parC mutations in A. baumannii were described in the 1990s [41,42], a substitution in
position 88 of parC has been more recently described [43]. Although these alterations have
been widely studied, terminological differences are usually found due to the use of the E.
coli gene sequences as the reference in protein alignments (particularly in older publica-
tions), which displaces the mutation position [26,43–45]. On the other hand, resistance to
the last-resort antibiotic colistin has been associated with mutations in lpxACD operon and
in pmrAB two components, both related to LPS biosynthesis, the pharmacological target
of polymyxins [26,46]. In this study, point mutations have been found in many genes,
but only one was common and exclusive for the colistin-resistant strains: Glu117Lys in
lpxD, not previously described as far as we know. No strain harbored the mcr-1 plasmid
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gene after it was manually searched for with the tblastn tool, traditionally linked with
polymyxin resistance [47]. Moreover, all strains owned RND multidrug efflux pumps
operons adeABC, adeFGH, and adeIJK, each one with a group of substrates, among which are
β-lactams, macrolides, tetracyclines, and fluoroquinolones [33,48]. The regulatory genes
adeL and adeN were also identified, which are responsible for the overexpression of adeFGH
and adeIJK, respectively, and the adeRS operon that regulates adeABC expression [48,49].
Likewise, all strains were positive to other efflux pumps, the SMR abeS which is able to
eliminate macrolides, and the MATE abeM, whose substrates are fluoroquinolones [33,49].
Constant and updated genomic information enables increasing knowledge about the
bacterial pathogens. For these five A. baumannii clinical isolates, RAST software was used to
classify the identified genes of the sequenced and annotated genomes in subsystems based
on their function [50]. RAST was not used for the annotation of antimicrobial determinants
because it usually appoints genes with enterobacterial names, although there was specific
terminology for another species. The largest number of genes with identified functions
were included in features associated with “Metabolism” (protein, nucleic, phosphorus,
sulfur, nitrogenous) (Figure 1). The following, based on the number of genes, were the
features related to cellular components (carbohydrates, amino acids, cofactors, lipids).
Another relevant group for both pathogenic relevance and genomic representation was the
“Virulence and defense” group, in which antimicrobial resistance genes are included, with an
average value of 84.6, which represents around 2.28% of the total. This is the largest number
in comparison with reference strains from the ESKAPE pathogen groups: Enterococcus
faecium DO 1.40% (44 “Virulence and defense” related genes in 3124 CDS), Staphylococcus
aureus NCTC8325 2.15% (58 in 2687), Klebsiella pneumoniae HS11286 1.18% (68 in 5731),
Pseudomonas aeruginosa PAO-1 1.17% (69 in 5858), and Enterobacter sp. EA-1 0.97% (126 in
12,965). It should also be noted that this bacterium has a small genome compare to the
others Gram-negative pathogens from this group, and hence fewer CDS.
Other studies focusing on differentiating between MDR and susceptible strains, as
well as pathogenic and environmental ones, showed greater differences in the num-
ber of elements classified for metabolic functions (including catabolism and cellular
processes) [17,51]. However, all strains tested here were pathogens with a multi-resistant
phenotype, so these differences could not be established.
In the last decade, comparative analysis of A. baumannii genomes has been performed,
mainly to determine pan- and core-genome sizes, which enables understanding of both
the relationship and variability among strains [19,51–54]. In this work, PanOCT and In-
teractiVenn softwares were used to visualize not only the sizes (Figure 3), but also the
relationship and number of shared genes among the five Illumina sequenced A. baumannii
strains [55,56]. Taxonomic relationships and evolutionary distances among strains were
determined using ANI [57] and DDH [58] scores including the well-known and publicly
accessible genome of the multi-resistant AYE strain (#GCA_000069245.1) in order to confirm
the species. Their relationship values ranged from 100 and 96.8% (ANI and DDH, respec-
tively) for the closest strains, to 78.4% (DDH score) for the most distant ones (Figure 2). As
ANI distances were determined for less restrictive values than DDH ones, they may lead
to the mistake of considering two similar strains as one, so for close genomes, DDH scores
are more recommended. Through the orthologs analysis, 5244 CDS for pan-genome and
2911 for core-genome were established. Accessory genes were between 102 (HUMV2790)
and 368 (HUMV1319). Comparing PanOCT with ANI/DDH results, similar relationships
were obtained, with HUMV2790 and HUMV3743 sharing more genes between each other
(362) than among the rest. The second largest group of shared genes was 127, including all
strains except HUMV2471, which also showed the lowest values in general in ANI/DDH
matrix. Pan-genome and core-genome sizes in other studies vary depending on the strain
set and isolate origin, being also affected by sample size, with pan-genome values between
3000 and 6500, similar to our results [52–54].
Acinetobacter baumannii human pathogenic strains are clinically relevant for their
high resistance rate. Plasmids, as mobile elements, may disseminate genetic resistance
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determinants [59,60]. Despite this pathogen relevance, information about A. baumannii
plasmids is scarce, with structures ranging from 2 kb to more than 100 kb [13,61]. In this
study, different approaches have been applied to identify and characterize A. baumannii
sequenced strains: PFGE with an S1 endonuclease digestion, PCR detection with specific A.
baumannii plasmids primers, and PLACNETw software as bioinformatic analysis.
Regarding the PFGE profile, as far as we know, this was never used before for Acineto-
bacter plasmid detection, but for patterns of chromosomic DNA [28]. For PCR detection,
specific primers for A. baumannii plasmids designed by Bertini et al. were used, in which
the authors grouped the resistance plasmid by replicase homology (19 groups). How-
ever, based on subsequent results, these authors’ PBRT scheme might be reviewed and
new homology groups added, due to the increasing number of this bacterium plasmid
sequence [13,53]. PLACNETw was used not only to detect, but also to identify the plasmid
type, which is limited by the annotated and deposited genomes [62].
Taking the results of the three approaches together, we obtained common predictions
in most strains, highlighting the importance of using different validating methods. In the
ATCC®19606TM strain, plasmid prediction was positive through two methods and the
PLACNETw putative plasmid had enough identity to be considered as a pMAC [63], which
is classified in Bertini GR8. Small-sized plasmids could be the reason for not obtaining a
PFGE prediction (Figure 4B). In the HUMV1319 strain, the PLACNETw server identified
a putative pMMCU3 plasmid of 8.9 kb, which is included in the Bertini classification as
GR2. The same results were obtained for one small HUMV2471 plasmid (8.9 kb), and a
high identity of the 6 kb plasmid with the pRAY structure [13]. The pMMCU3 sequence
similarities were confirmed through a Clustal W [64] alignment, being the strains that
harbored the blaOXA-24/40 gene typically carried by this mobile structure [38]. In HUMV2471,
two plasmids of 118.39 and 69.2 kb were also identified by PLACNETw and positively
identified with similar sizes in the PFGE gel, but not enough identity was obtained in
PLACNETw to classify them correctly, while the biggest one presented some similarity with
pABUH4-111 and pABTJ2 plasmids [59]. In HUMV2790, a band between 97 and 145.5 kb
with a PFGE analysis showed the presence of a big plasmid, which was also detected
with PLACNETw as a 105.1 kb structure identified as pABUH5-114, recently described for
the first time as a large A. baumannii plasmid that carries phage-related genes [53]. The
11.55 kb small one predicted with the bioinformatic tools as a putative pMMCU3 plasmid
could correlate with the Bertini GR2 positive classification. Furthermore, in HUMV3743
through PFGE identification, two plasmids of 97–145.5 kb and 48.5–97 kb were detected
in concordance with the PLACNETw putative plasmid sizes predicted (107 and 78 kb,
respectively), and identified as pABUH5-114 and pABUH1-74, respectively, included in
pACICU2-like plasmids which belong to Bertini GR6 [15,53].
Therefore, putting this all together, both traditional microbiology and genomic ap-
proaches could be useful to decipher the nosocomial pathogens’ behaviors when more
routine methods are not enough. In addition, using genomic tools for non-enterobacteria
would improve our knowledge of human pathogen bacteria even it is usually a bigger
challenge due to the lack of databases for them.
4. Materials and Methods
4.1. Bacterial Strains
Four A. baumannii clinical isolates were included in this work. All isolates were ob-
tained from different patients (standard service of routine) at the Hospital Universitario
Marqués de Valdecilla (HUMV) from Santander (Spain), whose phenotypes were previ-
ously described [22]. HUMV1319 and HUMV3743 were isolated from wound exudate,
HUMV2471 from sputum, and HUMV2790 from a skin ulcer. Reference strain A. baumannii
ATCC®19606TM [19] was also included. A. baumannii strains were routinely cultured on
blood agar (BA) plates, or Luria broth (LB) at 37 ◦C, and stock cultures were frozen at
−80 ◦C with 20% (vol/vol) glycerol.
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4.2. Antibiotic Susceptibility Assays
Antibiotic susceptibility was tested by microdilution following CLSI guidelines [25].
Seven compounds belonging to 6 of the main antibiotic families were tested: ampicillin,
meropenem, colistin, ciprofloxacin, erythromycin, gentamicin, and tetracycline. EUCAST
2019 breakpoints for Acinetobacter spp. [24] were used to classify the isolates as resistant
or susceptible. Briefly, bacterial suspension was adjusted to OD620 = 0.05, which equals
0.5 McFarland units. Antimicrobials were tested at the following ranges: ampicillin 1–
64 mg/L, meropenem 0.25–6 mg/L, colistin 0.125–8 mg/L, ciprofloxacin 0.06–4 mg/L,
erythromycin 2–128 mg/L, gentamicin 0.5–32 mg/L, and tetracycline 0.5–32 mg/L.
4.3. DNA Isolation and Sequencing
The total genomic sample of A. baumannii clinical strains and the ATCC®19606TM ref-
erence one was extracted and purified using the GeneJET genomic DNA (gDNA) isolation
kit (Thermo Scientific, Carlsbad, CA, USA) after growth on LB for 24 h at 37 ◦C. The gDNA
was submitted to Fisabio (Valencia, Spain) for Illumina (MiSeq 2 × 300 bp) sequencing.
DNA libraries were generated following the Nextera XT Illumina protocol (Nextera XT
library prep kit [catalog number FC-131-1024]). Next, 0.2 ng/µL of purified gDNA was
used to initiate the protocol. The multiplexing step was performed using the Nextera XT
index kit (catalog number FC-131-1096). The libraries were sequenced using a 2 × 300 bp
paired-end run (MiSeq v3 reagent kit [catalog number MS-102-3003] on a MiSeq sequencer
according to the manufacturer’s instructions [Illumina, Valencia, Spain]).
4.4. Genomic Assembly and Annotation
The whole-genome sequence was assembled using Unicycler v0.3.0.b with both paired
and unpaired reads [65].
Annotation of the genome sequence was performed with the Rapid Annotations using
Subsystems Technology (RAST) server, as well as Prokka 1.13 to identify the number of
coding sequences (CDS), subsystem feature counts, and RNA identification [32,50]. The
genotyping was performed using the PubMLST database [66].
Gene clusters related to the secondary metabolite biosynthetic were detected using
antiSMASH (bacterial version) [67]. For antimicrobial resistance genes, a preliminary
analysis using Prokka 1.13 [32] and ABRicate 0.8 software (https://www.github.com/
tseemann/abricate, accessed on: 1 June 2018) (Resfinder 3.2 database) [68], as well as
CARD database [30] for efflux pumps encoding genes were used. BLAST alignment with
the tblastn option (https://blast.ncbi.nlm.nih.gov/, accessed on: 1 June 2018) was used
to identify specific genes. The software MEGA7 was used for point mutation identifica-
tion [31], as well as the PointFinder database from ABRicate software.
4.5. Plasmid Prediction and Identifications
The PLACNETw server was used to predict feasible plasmids in Illumina sequenced
genomes [62]. Identification using the Bertini et al. [15] approach for PCR-based replicon
typing (PBRT) with specific A. baumannii resistance plasmid primers was also used to
detect and characterize the positive harboring strains. Plasmid presence identification by
Pulsed-field Gel Electrophoresis (PFGE) digestion was performed with a CHEF-DR® III
system (Bio-Rad, Hercules, CA, USA) as following. Bacteria were grown in LB overnight
(O/N) with shaking (175 rpm), and 500 µL of bacterial suspension was mixed with the
same volume of 2% LM agarose in TE buffer (10 mM Tris, 1 mM EDTA) for making plugs.
Then, 1 mL of lysis solution with 0.5 mg/mL of lysozyme was added and incubated O/N
at 37 ◦C with shaking. After, an equal volume of 0.5 mg/mL of proteinase K in ES (EDTA
0.5 M, sarcosyl 1%) buffer was added and incubated during 16–20 h at 56 ◦C in static. The
plugs were washed six times with pre-warmed TE buffer and then digested with 20 U of S1
restriction enzyme for 30 min at 37 ◦C. Electrophoresis was performed in a 1% agarose gel
at 6 V/cm and 14 ◦C with 0.5× TBE buffer. Pulse times ramped from 1 to 15 s for 6 h and
Antibiotics 2021, 10, 753 12 of 15
15 to 35 s for 16 h. Low range PFGE marker (New England Biolabs, Ipswich, MA, USA)
was used as the molecular size marker.
4.6. Strain Comparison and Pan-Genome Analysis
ANI [57] and DDH [58] values were calculated for each strain to determine evolution-
ary distances and to identify the species, using AYE [17] as a reference strain.
For pan-genome comparison, PanOCT software [55] was used to cluster orthologous
proteins, and the EggNOG v4.0 database [69,70] to annotate their functional categories.
InteractiVenn was used for diagram illustration [56].
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/antibiotics10070753/s1, Figure S1: Plasmid prediction with PLACNET of 5 A. baumannii
strains; Table S1: List of virulence genes of 5 A. baumannii strains.
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